What Patented Medicine Prices Review Board Guidelines 2021 requires
The Patented Medicine Prices Review Board (PMPRB) Guidelines 2021 require that the price of a patented medicine in Canada not exceed the median price of the same medicine in seven comparator countries, as per Section 4 of the Guidelines.
Pillar: Pharmaceuticals & Life Sciences · Authority: Patented Medicine Prices Review Board · Version: 1.0.1 · Last updated:
Primary source: https://www.pmprb-cepmb.gc.ca/en/index
SHA-256 integrity: e1a955df0796d1765524fd0d9dfa4f0503c74a0ae3a60c2f8010a80746be72f9
Primary Citations — 5 traced to source
- Patented Medicine Prices Review Board Guidelines 2021, Section 4 - International Price Comparison
- Patented Medicine Prices Review Board Guidelines 2021, Section 5 - Therapeutic Improvement Test
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/canada-pmprb-patented-medicine-prices-2021.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/canada-pmprb-patented-medicine-prices-2021.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/canada-pmprb-patented-medicine-prices-2021
- Back to registry: Browse all 10,090 compliance nodes